688076 ST诺泰
交易中 08-14 13:55:27
资讯
新帖
简况
非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨2.47%
市场透视 · 08-11
非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨2.47%
CRO概念盘中跳水,ST诺泰跌0.47%
市场透视 · 08-07
CRO概念盘中跳水,ST诺泰跌0.47%
非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨3.30%
市场透视 · 08-07
非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨3.30%
8月6日ST诺泰跌5.18%,招商蓝筹精选股票A基金重仓该股
证券之星 · 08-06
8月6日ST诺泰跌5.18%,招商蓝筹精选股票A基金重仓该股
ST诺泰(688076.SH)通过药品cGMP现场检查
智通财经 · 08-05
ST诺泰(688076.SH)通过药品cGMP现场检查
非酒精性脂肪性肝炎(NASH)概念盘中拉升,华东医药涨3.54%
市场透视 · 08-05
非酒精性脂肪性肝炎(NASH)概念盘中拉升,华东医药涨3.54%
非酒精性脂肪性肝炎(NASH)概念盘中跳水,众生药业跌7.34%
市场透视 · 08-04
非酒精性脂肪性肝炎(NASH)概念盘中跳水,众生药业跌7.34%
ST诺泰(688076.SH)收到注射用醋酸西曲瑞克、阿戈美拉汀片药品注册证书
智通财经网 · 07-31
ST诺泰(688076.SH)收到注射用醋酸西曲瑞克、阿戈美拉汀片药品注册证书
减肥药概念盘中拉升,翰宇药业涨5.08%
市场透视 · 07-31
减肥药概念盘中拉升,翰宇药业涨5.08%
卓悦榜|诺泰生物荣膺“年度医疗健康最佳战略投资机构”奖项
诺泰生物 · 07-30
卓悦榜|诺泰生物荣膺“年度医疗健康最佳战略投资机构”奖项
非酒精性脂肪性肝炎(NASH)概念盘中跳水,福瑞股份跌2.76%
市场透视 · 07-30
非酒精性脂肪性肝炎(NASH)概念盘中跳水,福瑞股份跌2.76%
ST诺泰涨5.07% 业绩预增与监管风险博弈
智选洞察 · 07-29
ST诺泰涨5.07% 业绩预增与监管风险博弈
新冠药物概念盘中拉升,众生药业涨6.47%
市场透视 · 07-29
新冠药物概念盘中拉升,众生药业涨6.47%
非酒精性脂肪性肝炎(NASH)概念盘中跳水,ST诺泰跌2.26%
市场透视 · 07-28
非酒精性脂肪性肝炎(NASH)概念盘中跳水,ST诺泰跌2.26%
诺泰生物造假“戴帽”,保荐人南京证券的“瑕疵”循环
蓝鲸财经 · 07-25
诺泰生物造假“戴帽”,保荐人南京证券的“瑕疵”循环
非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨4.29%
市场透视 · 07-25
非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨4.29%
减肥药概念盘中拉升,智飞生物涨8.82%
市场透视 · 07-24
减肥药概念盘中拉升,智飞生物涨8.82%
CRO概念盘中拉升,ST诺泰涨5.95%
市场透视 · 07-24
CRO概念盘中拉升,ST诺泰涨5.95%
非酒精性脂肪性肝炎(NASH)概念盘中跳水,迈瑞医疗跌0.80%
市场透视 · 07-24
非酒精性脂肪性肝炎(NASH)概念盘中跳水,迈瑞医疗跌0.80%
流感概念盘中拉升,汉商集团涨停
市场透视 · 07-23
流感概念盘中拉升,汉商集团涨停
加载更多
公司概况
公司名称:
江苏诺泰澳赛诺生物制药股份有限公司
所属行业:
医药制造业
上市日期:
2021-05-20
主营业务:
江苏诺泰澳赛诺生物制药股份有限公司的主营业务是聚焦多肽药物及小分子化药进行自主研发与定制研发生产。公司的主要产品是定制类产品及技术服务、自主选择产品。
发行价格:
15.57
{"stockData":{"symbol":"688076","market":"SH","secType":"STK","nameCN":"ST诺泰","latestPrice":44.83,"timestamp":1755150927000,"preClose":46,"halted":0,"volume":10027826,"delay":0,"changeRate":-0.0254,"floatShares":316000000,"shares":316000000,"eps":1.5526,"marketStatus":"交易中","change":-1.17,"latestTime":"08-14 13:55:27","open":45.81,"high":46.19,"low":43.99,"amount":451000000,"amplitude":0.0478,"askPrice":44.86,"askSize":53,"bidPrice":44.83,"bidSize":14,"shortable":0,"etf":0,"ttmEps":1.5526,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1755154800000},"marketStatusCode":2,"adr":0,"adjPreClose":46,"symbolType":"stock_kcb","openAndCloseTimeList":[[1755135000000,1755142200000],[1755147600000,1755154800000]],"highLimit":48.3,"lowLimit":43.7,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":316051897,"isCdr":false,"pbRate":5.29,"roa":"--","peRate":28.874147,"roe":"5.57%","epsLYR":1.88,"committee":-0.157895,"marketValue":14169000000,"turnoverRate":0.0317,"status":1,"floatMarketCap":14169000000},"requestUrl":"/m/hq/s/688076","defaultTab":"news","newsList":[{"id":"2558338446","title":"非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨2.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558338446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558338446?lang=zh_cn&edition=full","pubTime":"2025-08-11 10:05","pubTimestamp":1754877935,"startTime":"0","endTime":"0","summary":"08月11日,非酒精性脂肪性肝炎(NASH)概念盘中拉升,截至10点05分,非酒精性脂肪性肝炎(NASH)概念整体指数上涨1.02%,报1386.250点。从个股上来看,该概念的成分股中,福瑞股份涨2.47%,众生药业、ST诺泰、微芯生物涨幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为7459.31万,其中迈瑞医疗受到资金热捧,主力净流入3273.96万;拉长时间线来看,该板块近20日主力资金净流入6.29亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100535a6de9e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100535a6de9e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","BK0028","688076","300049","BK0096","BK0113","BK0114","BK0146","688321","BK0239"],"gpt_icon":0},{"id":"2557582940","title":"CRO概念盘中跳水,ST诺泰跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557582940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557582940?lang=zh_cn&edition=full","pubTime":"2025-08-07 10:12","pubTimestamp":1754532747,"startTime":"0","endTime":"0","summary":"08月07日,CRO概念盘中跳水,截至10点12分,CRO概念整体指数下跌1.06%,报584.320点。从个股上来看,该概念的成分股中,ST诺泰跌0.47%,宣泰医药、义翘神州、百诚医药跌幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-4.80亿,其中凯莱英受到资金热捧,主力净流入644.65万;拉长时间线来看,该板块近20日主力资金净流入-69.78亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807101227a479d0d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807101227a479d0d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","688247","BK0239"],"gpt_icon":0},{"id":"2557584231","title":"非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨3.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557584231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557584231?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:35","pubTimestamp":1754530540,"startTime":"0","endTime":"0","summary":"08月07日,非酒精性脂肪性肝炎(NASH)概念盘中拉升,截至09点35分,非酒精性脂肪性肝炎(NASH)概念整体指数上涨0.51%,报1390.160点。从个股上来看,该概念的成分股中,福瑞股份涨3.30%,微芯生物、ST诺泰、众生药业涨幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-1950.36万,其中ST诺泰受到资金热捧,主力净流入460.96万;拉长时间线来看,该板块近20日主力资金净流入2.81亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080709354094d488f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080709354094d488f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0114","688076","BK0239","688321","300049","BK0113","BK0028","BK0146","BK0096","BK0251"],"gpt_icon":0},{"id":"2557329265","title":"8月6日ST诺泰跌5.18%,招商蓝筹精选股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2557329265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557329265?lang=zh_cn&edition=full","pubTime":"2025-08-06 16:15","pubTimestamp":1754468132,"startTime":"0","endTime":"0","summary":"证券之星消息,8月6日ST诺泰跌5.18%,收盘报46.7元,换手率5.74%,成交量18.14万手,成交额8.66亿元。重仓ST诺泰的前十大公募基金请见下表:该股最近90天内共有5家机构给出评级,买入评级5家。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共18家,其中持有数量最多的公募基金为招商基金的招商蓝筹精选股票A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080600025416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2557667013","title":"ST诺泰(688076.SH)通过药品cGMP现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2557667013","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557667013?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:20","pubTimestamp":1754382042,"startTime":"0","endTime":"0","summary":"智通财经APP讯,ST诺泰 发布公告,公司于近日收到PIC/S成员巴西国家卫生监督局签发的《药品生产质量管理规范证书》CBPF-GMP证书。本次检查覆盖公司连云港工厂cGMP系统,产品包括原料药司美格鲁肽及利拉鲁肽。公司本次司美格鲁肽、利拉鲁肽原料药生产线通过巴西卫生监督局cGMP现场检查,是继美国食品药品监督管理局、韩国食品药品安全部后通过的又一海外官方合规检查。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ST诺泰(688076.SH)通过药品cGMP现场检查","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2557350046","title":"非酒精性脂肪性肝炎(NASH)概念盘中拉升,华东医药涨3.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557350046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557350046?lang=zh_cn&edition=full","pubTime":"2025-08-05 14:36","pubTimestamp":1754375774,"startTime":"0","endTime":"0","summary":"08月05日,非酒精性脂肪性肝炎(NASH)概念盘中拉升,截至14点36分,非酒精性脂肪性肝炎(NASH)概念整体指数上涨1.00%,报1384.490点。从个股上来看,该概念的成分股中,华东医药涨3.54%,ST诺泰、康弘药业、微芯生物涨幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-580.72万,其中通化东宝受到资金热捧,主力净流入4524.58万;拉长时间线来看,该板块近20日主力资金净流入2.97亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080514361494d098d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080514361494d098d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0187","BK0196","BK0132","BK0175","BK0188","BK0209","688076","LU1969619763.USD","BK0239","LU2328871848.SGD","000963","BK0183","688321"],"gpt_icon":0},{"id":"2556879079","title":"非酒精性脂肪性肝炎(NASH)概念盘中跳水,众生药业跌7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556879079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556879079?lang=zh_cn&edition=full","pubTime":"2025-08-04 09:46","pubTimestamp":1754271968,"startTime":"0","endTime":"0","summary":"08月04日,非酒精性脂肪性肝炎(NASH)概念盘中跳水,截至09点46分,非酒精性脂肪性肝炎(NASH)概念整体指数下跌0.50%,报1353.880点。从个股上来看,该概念的成分股中,众生药业跌7.34%,微芯生物、康弘药业、ST诺泰跌幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-9900.89万,其中天士力受到资金热捧,主力净流入18.25万;拉长时间线来看,该板块近20日主力资金净流入2.32亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094608a6d1389e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094608a6d1389e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0188","002317","688076","BK0239"],"gpt_icon":0},{"id":"2555000864","title":"ST诺泰(688076.SH)收到注射用醋酸西曲瑞克、阿戈美拉汀片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2555000864","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555000864?lang=zh_cn&edition=full","pubTime":"2025-07-31 16:39","pubTimestamp":1753951144,"startTime":"0","endTime":"0","summary":"智通财经APP讯,ST诺泰 公告,公司近日收到国家药品监督管理局核准签发的注射用醋酸西曲瑞克、阿戈美拉汀片的《药品注册证书》。公告显示,醋酸西曲瑞克作为第三代GnRH拮抗剂,在辅助生殖技术中相较于其他同类药物具有独特的临床优势。此外,阿戈美拉汀还有极低性功能障碍风险、对体重影响小、耐受性好、撤药反应少等优势,在抑郁症伴失眠市场占据着重要的地位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ST诺泰(688076.SH)收到注射用醋酸西曲瑞克、阿戈美拉汀片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2555007190","title":"减肥药概念盘中拉升,翰宇药业涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555007190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555007190?lang=zh_cn&edition=full","pubTime":"2025-07-31 09:44","pubTimestamp":1753926278,"startTime":"0","endTime":"0","summary":"07月31日,减肥药概念盘中拉升,截至09点44分,减肥药概念整体指数上涨1.02%,报1274.840点。从个股上来看,该概念的成分股中,翰宇药业涨5.08%,昊帆生物、ST诺泰、皓元医药涨幅居前。从资金上来看,截止发稿,减肥药概念主力净流入为-3964.40万,其中翰宇药业受到资金热捧,主力净流入5966.30万;拉长时间线来看,该板块近20日主力资金净流入-53.27亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731094438a6ca8cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731094438a6ca8cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300199","BK0239","BK0188","BK0077","BK0070","688131","688076","BK0028"],"gpt_icon":0},{"id":"2555501785","title":"卓悦榜|诺泰生物荣膺“年度医疗健康最佳战略投资机构”奖项","url":"https://stock-news.laohu8.com/highlight/detail?id=2555501785","media":"诺泰生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555501785?lang=zh_cn&edition=full","pubTime":"2025-07-30 15:37","pubTimestamp":1753861058,"startTime":"0","endTime":"0","summary":"2025年7月30日, “第九届医疗健康投资卓悦榜”正式发布,诺泰生物荣膺“年度医疗健康最佳战略投资机构”奖项。医疗健康投资卓悦榜”已连续发布进入第九个年头,由浩悦资本以“公平公正、开放中立”为基石评选。诺泰生物实施“时间领先、技术领先”战略,前瞻性布局多肽、寡核苷酸等生物医药技术平台及衍生的高潜力品种。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730162257a6c952b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730162257a6c952b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159760","688076","BK0239"],"gpt_icon":0},{"id":"2555009373","title":"非酒精性脂肪性肝炎(NASH)概念盘中跳水,福瑞股份跌2.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555009373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555009373?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:52","pubTimestamp":1753840377,"startTime":"0","endTime":"0","summary":"07月30日,非酒精性脂肪性肝炎(NASH)概念盘中跳水,截至09点52分,非酒精性脂肪性肝炎(NASH)概念整体指数下跌0.50%,报1376.980点。从个股上来看,该概念的成分股中,福瑞股份跌2.76%,微芯生物、ST诺泰、华东医药跌幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-4587.24万,其中迈瑞医疗受到资金热捧,主力净流入7240.13万;拉长时间线来看,该板块近20日主力资金净流入-4.81亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095257a6c8b653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095257a6c8b653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0114","BK0113","BK0028","688321","300049","BK0096","BK0239","BK0146","BK0251","688076"],"gpt_icon":0},{"id":"2555086863","title":"ST诺泰涨5.07% 业绩预增与监管风险博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2555086863","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555086863?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:26","pubTimestamp":1753755981,"startTime":"0","endTime":"0","summary":"ST诺泰股价大幅上涨,最新价48.27元,涨跌幅为5.07%。资金博弈与监管冲击共振ST诺泰近期净流出源于多空资金激烈博弈。截至7月28日,近5个交易日主力资金净流出规模达1.15亿元,显示短期筹码仍在剧烈交换。行政处罚导致未来12个月无法股权再融资,加剧了机构投资者的避险情绪。东方财富数据显示,近3年海外客户收入复合增长率达28%,但监管审查与债务结构优化进程存在变数,估值修复斜率将取决于基本面改善与政策风险的动态平衡。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729102627a468ae8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729102627a468ae8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2555088789","title":"新冠药物概念盘中拉升,众生药业涨6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555088789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555088789?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:38","pubTimestamp":1753753109,"startTime":"0","endTime":"0","summary":"07月29日,新冠药物概念盘中拉升,截至09点38分,新冠药物概念整体指数上涨0.53%,报784.320点。从个股上来看,该概念的成分股中,众生药业涨6.47%,佛慈制药、广生堂、ST诺泰涨幅居前。从资金上来看,截止发稿,新冠药物概念主力净流入为-1.61亿,其中众生药业受到资金热捧,主力净流入5775.66万;拉长时间线来看,该板块近20日主力资金净流入-60.10亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072909382994c066a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072909382994c066a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002317","688076","BK0188","BK0239","BK0077"],"gpt_icon":0},{"id":"2554219742","title":"非酒精性脂肪性肝炎(NASH)概念盘中跳水,ST诺泰跌2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554219742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554219742?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:46","pubTimestamp":1753667174,"startTime":"0","endTime":"0","summary":"07月28日,非酒精性脂肪性肝炎(NASH)概念盘中跳水,截至09点46分,非酒精性脂肪性肝炎(NASH)概念整体指数下跌0.55%,报1300.480点。从个股上来看,该概念的成分股中,ST诺泰跌2.26%,福瑞股份、微芯生物、通化东宝跌幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-3185.04万,其中华东医药受到资金热捧,主力净流入777.10万;拉长时间线来看,该板块近20日主力资金净流入-8.07亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728094614a6c4e242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728094614a6c4e242&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","688076","BK0188","BK0239","600867"],"gpt_icon":0},{"id":"2554577727","title":"诺泰生物造假“戴帽”,保荐人南京证券的“瑕疵”循环","url":"https://stock-news.laohu8.com/highlight/detail?id=2554577727","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554577727?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:31","pubTimestamp":1753428711,"startTime":"0","endTime":"0","summary":"根据证监会调查,2021年12月,诺泰生物向浙江华贝药业转让药品技术,确认3000万元收入。这纸罚单不仅让诺泰生物“戴帽”,更让市场开始重新审视其保荐机构南京证券的责任。然而当诺泰生物因财务造假被重罚时,人们发现南京证券的保荐项目瑕疵远不止这一单。当诺泰生物在ST首日股价下挫时,南京证券8.35元/股的午盘价同样泛着绿意。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072515335794ba0771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072515335794ba0771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601990","688076","BK0239","BK0276"],"gpt_icon":0},{"id":"2554732978","title":"非酒精性脂肪性肝炎(NASH)概念盘中拉升,福瑞股份涨4.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554732978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554732978?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:46","pubTimestamp":1753408009,"startTime":"0","endTime":"0","summary":"07月25日,非酒精性脂肪性肝炎(NASH)概念盘中拉升,截至09点46分,非酒精性脂肪性肝炎(NASH)概念整体指数上涨1.11%,报1319.620点。从个股上来看,该概念的成分股中,福瑞股份涨4.29%,ST诺泰、华东医药、天士力涨幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-1908.83万,其中迈瑞医疗受到资金热捧,主力净流入2138.89万;拉长时间线来看,该板块近20日主力资金净流入-6.53亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509464994b96e0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509464994b96e0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0114","BK0251","BK0096","688076","BK0113","BK0239","BK0146","300049","BK0028"],"gpt_icon":0},{"id":"2553276901","title":"减肥药概念盘中拉升,智飞生物涨8.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553276901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553276901?lang=zh_cn&edition=full","pubTime":"2025-07-24 13:02","pubTimestamp":1753333342,"startTime":"0","endTime":"0","summary":"07月24日,减肥药概念盘中拉升,截至13点02分,减肥药概念整体指数上涨2.00%,报1224.380点。从个股上来看,该概念的成分股中,智飞生物涨8.82%,ST诺泰、普蕊斯等3只股涨幅超过5%。从资金上来看,截止发稿,减肥药概念主力净流入为-1.29亿,其中智飞生物受到资金热捧,主力净流入1.06亿;拉长时间线来看,该板块近20日主力资金净流入-54.73亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724130222a4607d71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724130222a4607d71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300122","LU1064130708.USD","BK0239","BK0046","LU1328615791.USD","BK0077","688076","BK0196","LU2580892862.HKD","BK0188","LU2580892789.USD","LU2148510915.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2553222133","title":"CRO概念盘中拉升,ST诺泰涨5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553222133?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:48","pubTimestamp":1753321699,"startTime":"0","endTime":"0","summary":"07月24日,CRO概念盘中拉升,截至09点48分,CRO概念整体指数上涨1.21%,报556.170点。从个股上来看,该概念的成分股中,ST诺泰涨5.95%,博腾股份、凯莱英、睿智医药涨幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-1.04亿,其中凯莱英受到资金热捧,主力净流入3941.01万;拉长时间线来看,该板块近20日主力资金净流入-14.37亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724094819a4602246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724094819a4602246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076","06821"],"gpt_icon":0},{"id":"2553222158","title":"非酒精性脂肪性肝炎(NASH)概念盘中跳水,迈瑞医疗跌0.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553222158?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:45","pubTimestamp":1753321501,"startTime":"0","endTime":"0","summary":"07月24日,非酒精性脂肪性肝炎(NASH)概念盘中跳水,截至09点44分,非酒精性脂肪性肝炎(NASH)概念整体指数下跌0.60%,报1296.350点。从个股上来看,该概念的成分股中,迈瑞医疗跌0.80%,福瑞股份、康弘药业、众生药业跌幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-839.11万,其中ST诺泰受到资金热捧,主力净流入1718.93万;拉长时间线来看,该板块近20日主力资金净流入-11.65亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072409450194b72de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072409450194b72de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0005HP3H50.USD","LU2213484517.USD","LU1820825898.SGD","LU0405327148.USD","SGXZ81163826.USD","LU1997245094.SGD","LU2348773727.SGD","LU1064131003.USD","LU2348774022.SGD","LU0594300179.USD","LU1997245177.USD","IE0031814852.USD","688076","LU1064130708.USD","LU0084288322.USD","LU1794554557.SGD","LU1023057109.AUD","LU2424517915.HKD","BK0251","LU0359202008.SGD","LU1720050803.USD","LU1734074674.USD","LU1781817850.SGD","IE0008368742.USD","LU1580142542.USD","LU0650527681.SGD","LU0823426308.USD","LU0405327494.USD","LU2488822045.USD","LU0327786744.USD","SGXZ49509284.SGD","LU2148510915.USD","LU0605514214.HKD","LU1146622755.USD","LU2153591404.USD","LU2153592121.USD","LU1934453819.USD","BK0239","IE00B29SXG58.USD","LU1688375341.USD","LU0359201612.USD","IE00B031J352.USD","300760","IE00B031HY20.USD","LU0594300419.USD","LU0823426480.USD","LU0572944931.SGD","LU1655091616.SGD","LU1979443071.USD"],"gpt_icon":0},{"id":"2553298623","title":"流感概念盘中拉升,汉商集团涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2553298623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553298623?lang=zh_cn&edition=full","pubTime":"2025-07-23 10:25","pubTimestamp":1753237530,"startTime":"0","endTime":"0","summary":"07月23日,流感概念盘中拉升,截至10点25分,流感概念整体指数上涨1.03%,报1076.560点。从个股上来看,该概念的成分股中,汉商集团涨停,博腾股份、东北制药等5只股涨幅超过5%。从资金上来看,截止发稿,流感概念主力净流入为1.12亿,其中ST诺泰受到资金热捧,主力净流入8626.71万;拉长时间线来看,该板块近20日主力资金净流入-70.14亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723102530a6bc29de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723102530a6bc29de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600774","BK0239","BK0209","688076"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1755150930403,"stockEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":0.1822},{"period":"3month","weight":0.2355},{"period":"6month","weight":0.2986},{"period":"1year","weight":0.0858},{"period":"ytd","weight":0.2581}],"compareEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.0465},{"period":"3month","weight":0.0895},{"period":"6month","weight":0.1006},{"period":"1year","weight":0.2844},{"period":"ytd","weight":0.099}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏诺泰澳赛诺生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"12886人(较上一季度减少5.10%)","perCapita":"24526股","listingDate":"2021-05-20","address":"江苏省连云港市连云区经济技术开发区临浦路28号","registeredCapital":"31605万元","survey":" 江苏诺泰澳赛诺生物制药股份有限公司的主营业务是聚焦多肽药物及小分子化药进行自主研发与定制研发生产。公司的主要产品是定制类产品及技术服务、自主选择产品。","listedPrice":15.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST诺泰(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST诺泰(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST诺泰,688076,ST诺泰股票,ST诺泰股票老虎,ST诺泰股票老虎国际,ST诺泰行情,ST诺泰股票行情,ST诺泰股价,ST诺泰股市,ST诺泰股票价格,ST诺泰股票交易,ST诺泰股票购买,ST诺泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST诺泰(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST诺泰(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}